260 related articles for article (PubMed ID: 16135466)
1. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
Madhusudan S; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Ganesan TS
J Clin Oncol; 2005 Sep; 23(25):5950-9. PubMed ID: 16135466
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.
Madhusudan S; Foster M; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Talbot DC; Ganesan TS; Harris AL
Clin Cancer Res; 2004 Oct; 10(19):6528-34. PubMed ID: 15475440
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
Monk JP; Phillips G; Waite R; Kuhn J; Schaaf LJ; Otterson GA; Guttridge D; Rhoades C; Shah M; Criswell T; Caligiuri MA; Villalona-Calero MA
J Clin Oncol; 2006 Apr; 24(12):1852-9. PubMed ID: 16622259
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
Tsimberidou AM; Giles FJ; Duvic M; Kurzrock R
J Am Acad Dermatol; 2004 Aug; 51(2):200-4. PubMed ID: 15280837
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
Landells I; Paller AS; Pariser D; Kricorian G; Foehl J; Molta C; Freundlich B
Eur J Dermatol; 2010; 20(3):323-8. PubMed ID: 20185386
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.
Tsimberidou AM; Thomas D; O'Brien S; Andreeff M; Kurzrock R; Keating M; Albitar M; Kantarjian H; Giles F
Cancer Chemother Pharmacol; 2002 Sep; 50(3):237-42. PubMed ID: 12203106
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
9. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica.
Cohen SP; Bogduk N; Dragovich A; Buckenmaier CC; Griffith S; Kurihara C; Raymond J; Richter PJ; Williams N; Yaksh TL
Anesthesiology; 2009 May; 110(5):1116-26. PubMed ID: 19387178
[TBL] [Abstract][Full Text] [Related]
14. Treatment of erythrodermic psoriasis with etanercept.
Esposito M; Mazzotta A; de Felice C; Papoutsaki M; Chimenti S
Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
de Vlam K; Lories RJ
Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of etanercept for treating ankylosing spondylitis].
Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.
Don BR; Spin G; Nestorov I; Hutmacher M; Rose A; Kaysen GA
J Pharm Pharmacol; 2005 Nov; 57(11):1407-13. PubMed ID: 16259772
[TBL] [Abstract][Full Text] [Related]
18. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Gordon K; Korman N; Frankel E; Wang H; Jahreis A; Zitnik R; Chang T
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]